Dr. Steven Kang, MD

NPI: 1912189051
Total Payments
$306,739
2024 Payments
$132.43
Companies
9
Transactions
812

Payment Breakdown by Category

Other$215,072 (70.1%)
Travel$72,685 (23.7%)
Food & Beverage$15,840 (5.2%)
Consulting$3,000 (1.0%)
Education$141.84 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $215,072 100 70.1%
Travel and Lodging $72,685 462 23.7%
Food and Beverage $15,840 244 5.2%
Consulting Fee $3,000 3 1.0%
Education $141.84 3 0.0%

Top Paying Companies

Company Total Records Latest Year
Shire North American Group Inc $264,881 702 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $39,728 94 $0 (2022)
Gilead Sciences, Inc. $1,600 1 $0 (2022)
Octapharma USA, Inc. $237.57 9 $0 (2024)
Alexion Pharmaceuticals, Inc. $99.32 1 $0 (2017)
New York Blood Center, Inc. $88.84 2 $0 (2018)
Ipsen Biopharmaceuticals, Inc $53.00 1 $0 (2024)
GENZYME CORPORATION $28.20 1 $0 (2024)
Novo Nordisk Inc $22.89 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $132.43 4 Ipsen Biopharmaceuticals, Inc ($53.00)
2023 $20.93 1 Octapharma USA, Inc. ($20.93)
2022 $9,520 27 Takeda Pharmaceuticals U.S.A., Inc. ($7,920)
2021 $11,703 16 Takeda Pharmaceuticals U.S.A., Inc. ($11,678)
2020 $20,131 53 Takeda Pharmaceuticals U.S.A., Inc. ($20,131)
2019 $100,642 251 Shire North American Group Inc ($100,554)
2018 $86,765 217 Shire North American Group Inc ($86,644)
2017 $77,826 243 Shire North American Group Inc ($77,682)

All Payment Transactions

812 individual payment records from CMS Open Payments — Page 1 of 33

Date Company Product Nature Form Amount Type
08/14/2024 Ipsen Biopharmaceuticals, Inc Onivyde (Drug) Education In-kind items and services $53.00 General
Category: Oncology
04/04/2024 GENZYME CORPORATION CABLIVI (Biological) Food and Beverage In-kind items and services $28.20 General
Category: Hematology
03/15/2024 Octapharma USA, Inc. BALFAXAR (Biological) Food and Beverage In-kind items and services $14.55 General
Category: INTENSIVE CAREEMERGENCY
03/05/2024 Octapharma USA, Inc. BALFAXAR (Biological) Food and Beverage In-kind items and services $36.68 General
Category: INTENSIVE CAREEMERGENCY
12/03/2023 Octapharma USA, Inc. Food and Beverage In-kind items and services $20.93 General
10/18/2022 Gilead Sciences, Inc. Consulting Fee Cash or cash equivalent $1,600.00 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $125.00 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $106.09 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $94.16 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $64.72 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $53.06 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $45.00 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $25.35 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $18.93 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $18.36 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $17.17 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $15.00 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $5.00 General
10/06/2022 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $2.36 General
08/24/2022 Takeda Pharmaceuticals U.S.A., Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,428.00 General
07/26/2022 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $1,400.29 General
07/26/2022 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $248.86 General
05/25/2022 Takeda Pharmaceuticals U.S.A., Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $962.50 General
02/01/2022 Takeda Pharmaceuticals U.S.A., Inc. Travel and Lodging In-kind items and services $84.00 General
02/01/2022 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $48.79 General

About Dr. Steven Kang, MD

Dr. Steven Kang, MD is a Blood Banking & Transfusion Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912189051.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Kang, MD has received a total of $306,739 in payments from pharmaceutical and medical device companies, with $132.43 received in 2024. These payments were reported across 812 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($215,072).

Practice Information

  • Specialty Blood Banking & Transfusion Medicine
  • Location Brooklyn, NY
  • Active Since 11/30/2007
  • Last Updated 09/04/2015
  • Taxonomy Code 207ZB0001X
  • Entity Type Individual
  • NPI Number 1912189051

Products in Payments

  • ADVATE (Biological) $255,688
  • OBIZUR (Biological) $27,162
  • VONVENDI (Biological) $2,912
  • ADYNOVATE (Biological) $430.21
  • SOLIRIS (Drug) $99.32
  • FIBRYGA (Biological) $65.95
  • WILATE (Biological) $53.22
  • Onivyde (Drug) $53.00
  • BALFAXAR (Biological) $51.23
  • OCTAPLAS (Biological) $46.24
  • CABLIVI (Biological) $28.20
  • REBINYN (Drug) $22.89

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Blood Banking & Transfusion Medicine Doctors in Brooklyn